StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Allergen's (AGN) Price Target Reduced to $282 at Deutsche Bank
April 6, 2016 3:40 PM
Deutsche Bank maintained a Buy rating on Allergen (NYSE: AGN) but lowered its price target to $282.00 (from $339.00). Earlier ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
UBS Cuts Allergan (AGN) PT, Ests But Remains Above Consensus
April 7, 2016 8:41 AM
Jefferies Reiterates Buy on Pfizer (PFE) Post Allergen Collapse, PT Trimmed to $39
April 7, 2016 8:23 AM
Allergan (AGN) Affirms Termination of Pfizer (PFE) Merger; Affirms Strength as Standalone Company
April 6, 2016 6:47 AM
Pfizer (PFE) Announces Termination of Merger Agreement with Allergan (AGN)
April 6, 2016 6:45 AM
Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer Transaction
April 6, 2016 6:45 AM
Pfizer Announces Termination of Proposed Combination with Allergan
April 6, 2016 6:45 AM
